{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-026640","form_type":"8-K","ticker":"ABEO","cik":"0000318306","company_name":"ABEONA THERAPEUTICS INC.","filed_at":"2024-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.485571+00:00","generated_at":"2026-05-31T22:41:02.268361+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Abeona Therapeutics amends bylaws to allow 24-hour notice for special board meetings via electronic transmission","bullets":["Board approved amendment and restatement of bylaws on July 5, 2024, effective July 8, 2024.","Special board meetings can now be called with at least 24 hours' notice personally or by telephone, email, or other electronic means.","No other material changes to the bylaws disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-026640","json":"https://secwatch.observer/filing/0001493152-24-026640.json","markdown":"https://secwatch.observer/filing/0001493152-24-026640.md","text":"https://secwatch.observer/filing/0001493152-24-026640.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026640/0001493152-24-026640-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026640/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T22:41:02.268361+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}